中文名称: 氯沙坦钾 促销
英文名称: Losartan potassium
CAS No: 124750-99-8
分子式: C22H22ClKN6O
分子量: 461
L10419 氯沙坦钾 ≥98% (psaitong)
包装规格:
100g in glass bottle
溶解性:
溶于水(20mg/mL),溶于DMSO(≥50mg/mL)
产品描述:

基本信息

产品编号:

L10419

产品名称:

Losartan potassium

CAS:

124750-99-8

 

储存条件

粉末

室温

四年

 

 

分子式:

C22H22ClKN6O

溶于液体

-80℃

6个月

分子量:

461.00

-20℃

1个月

化学名: 

potassium;[2-butyl-5-chloro-3-[[4-[2-(1,2,3-triaza-4-azanidacyclopenta-2,5-dien-5-yl)phenyl]phenyl]methyl]imidazol-4-yl]methanol

Solubility (25°C):

 

体外:

 

DMSO

92mg/mL (199.12mM)

Ethanol

92mg/mL (199.12mM)

Water

92mg/mL (199.12mM)

体内(现配现用):

Saline

30mg/mL

1mg/ml表示微溶或不溶。

普西唐提供的所有化合物浓度为内部测试所得,实际溶液度可能与公布值有所偏差,属于正常的批间细微差异现象。

请根据产品在不同溶剂中的溶解度选择合适的溶剂配制储备液;⼀旦配成溶液,请分装保存,避免反复冻融造成的产品失效。

 

制备储备液

 

浓度

 

溶液体积

质量

 

1mg

 

5mg

 

10mg

1mM

2.1645mL

10.8223mL

21.6446mL

5mM

0.4329mL

2.1645mL

4.3289mL

10mM

0.2164mL

1.0822mL

2.1645mL

50mM

0.0433mL

0.2164mL

0.4329mL

 

生物活性

产品描述

一种血管紧张素 II 受体 1 型 (AT1)拮抗剂,与血管紧张素 II 与 AT1 的结合竞争,IC50 为 20nM。

靶点

AT1 receptor

20nM

 

体外研究

Losartan competes with the binding of angiotensin II to AT1 receptors.The concentration that inhibits 50% of the binding of angiotensin II (IC50) is 20nM.Losartan (40μM) affects ISC but prevents the effect of ANGII on ISC.Losartan significantly reduces Ang II-mediated cell proliferation in endometrial cancer cells.The combination of losartan and anti-miR-155 has a significantly greater antiproliferative effect compared to each drug alone.

体内研究

Losartan (0.6g/L,p.o.) -treated Fbn1C1039G/+mice show a reduction in distal airspace caliber relative to placebo-treated Fbn1C1039G/+animals.The doses of losartan and propranolol are titrated to achieve comparable hemodynamic effects.Analysis of pSmad2 nuclear staining reveals that losartan antagonizes TGF-β signaling in the aortic wall of Fbn1C1039G/+mice.Losartan can improve disease manifestations in the lungs,an event that cannot plausibly relate to improved hemodynamics.Losartan (10mg/kg,intraarterial injection) increases blood angiotensin levels four- to sixfold.Losartan (10mg/kg,i.p.) increases plasma renin levels 100-fold;plasma angiotensinogen levels decreases to 24% of control;and plasma aldosterone levels are unchanged.

 

推荐实验方法(仅供参考)

细胞实验:

 

An MTT assay is used to measure cell proliferation and viability.For the assay,5000 cells in 200μL media per well are seeded in a 96 well plate.After overnight incubation to allow for cell attachment,the medium is removed by suction.MTT at 1mg/mL concentration in serum-free medium is added and then incubated for 4 h at 37℃.After removal of MTT solution,100μL of DMSO is added to dissolve formazan crystals.Absorbance at 570nm and at 600nm as a reference is then measured using a microplate reader.The difference in absorbance is thus relative to the extent of cell survival.

 

动物实验:

 

Female Fbn1C1039G/+mice undergo timed matings with wild-type male mice.At 14.5d post-coitum,pregnant female Fbn1 C1039G/+mice are treated with oral losartan (0.6g/L in drinking water;n=10),propranolol (0.5g/L;n=6) or placebo (n=12).Therapy is continued throughout lactation and after weaning until 10 months of age.Mice are sacrificed and examined using the techniques described above.Propranolol is used for comparison with losartan because β-adrenergic receptor blockade is the current albeit controversial standard of care to modulate abnormal growth of the aortic root in MFS.Beginning at 7 weeks of age,wild-type and Fbn1C1039G/+mice are treated with oral losartan (0.6g/L in drinking water;n=5),propranolol (0.5g/L;n=7) or placebo (n=10).Mice are continued on oral therapy for 6 months and then sacrificed.

保存条件:
室温
UN码:
HazardClass:
危害声明:
安全说明:
搜索质检报告(COA)
参考文献 & 客户发表文献

本计算器可帮助您计算出特定溶液中溶质的质量、溶液浓度和体积之间的关系,公式为:
质量 (g) = 浓度 (mol/L) x 体积 (L) x 分子量 (g/mol)

摩尔浓度计算公式

  • =
    *
    *
    *选择对应的单位 *空出希望得到的变量,填写另外两个变量

用本工具协助配置特定浓度的溶液,使用的计算公式为:
开始浓度 x 开始体积 = 最终浓度 x 最终体积

稀释公式

稀释公式一般简略地表示为:C1V1 = C2V2 ( 输入 输出 )

  • * = *

连续稀释计算器方程

  • 连续稀释

  • 初始浓度:
  • 稀释倍数:
  • 计算结果

  • C1=C0/X C1: LOG(C1):
    C2=C1/X C2: LOG(C2):
    C3=C2/X C3: LOG(C3):
    C4=C3/X C4: LOG(C4):
    C5=C4/X C5: LOG(C5):
    C6=C5/X C6: LOG(C6):
    C7=C6/X C7: LOG(C7):
    C8=C7/X C8: LOG(C8):